1. Diabetes Mellitus and Colon Carcinogenesis: Expectation for Inhibition of Colon Carcinogenesis by Oral Hypoglycemic Drugs
   Junichi Kato et al, 2019, Gastrointestinal Disorders CrossRef
2. Inhibition of dipeptidyl peptidase IV prevents high fat diet-induced liver cancer angiogenesis by downregulating chemokine ligand 2
   Chen-Jie Qin et al, 2018, Cancer Letters CrossRef
3. CXCL5 and CXCL14, but not CXCL16 as potential biomarkers of colorectal cancer
   Monika Zajkowska et al, 2023, Scientific Reports CrossRef
4. The DPP-IV inhibitor saxagliptin promotes the migration and invasion of papillary thyroid carcinoma cells via the NRF2/HO1 pathway
   Liang He et al, 2020, Medical Oncology CrossRef
5. Attenuation of diethyl nitrosamine-induced hepatocellular carcinoma by taxifolin and/or alogliptin: The interplay between toll-like receptor 4, transforming growth factor beta-1, and apoptosis
   AM Kabel et al, 2021, Human & Experimental Toxicology CrossRef
6. Dipeptidyl Peptidase (DPP)-4 Inhibitor Impairs the Outcomes of Patients with Type 2 Diabetes Mellitus After Curative Resection for Colorectal Cancer
   Akira Saito et al, 2021, Cancer Research Communications CrossRef
7. CD26/DPP4 - a potential biomarker and target for cancer therapy
   Njanja Enz et al, 2019, Pharmacology & Therapeutics CrossRef
8. Chemokines in progression, chemoresistance, diagnosis, and prognosis of colorectal cancer
   Qian Zou et al, 2022, Frontiers in Immunology CrossRef
9. Phytochemicals in Garlic Extract Inhibit Therapeutic Enzyme DPP-4 and Induce Skeletal Muscle Cell Proliferation: A Possible Mechanism of Action to Benefit the Treatment of Diabetes Mellitus
   Poonam Kalhotra et al, 2020, Biomolecules CrossRef
10. Crosstalk between incretin hormones, Th17 and Treg cells in inflammatory diseases
    Eloisa Martins da Silva et al, 2022, Peptides CrossRef
11. Does DPP-IV Inhibition Offer New Avenues for Therapeutic Intervention in Malignant Disease?
    Petr Busek et al, 2022, Cancers CrossRef